Pat Beyer - Oct 29, 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role: President Int'l & Global Ortho
Signature: /s/ Sarah M. Oliker for Pat Beyer by Power of Attorney
Stock symbol: CNMD
Transactions as of: Oct 29, 2021
Transactions value $: -$8,075,751
Form type: 4
Date filed: 11/2/2021, 04:59 PM
Previous filing: May 18, 2021
Next filing: Nov 5, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNMD	Common Stock	Options Exercise	$2.2M	+55.3K	+708.34%	$39.87	63.1K	Oct 29, 2021	Direct
transaction	CNMD	Common Stock	Tax liability	-$4.34M	-30K	-47.57%	$144.62	33.1K	Oct 29, 2021	Direct
transaction	CNMD	Common Stock	Sale	-$403K	-2.79K	-8.43%	$144.50	30.3K	Oct 29, 2021	Direct	F1
transaction	CNMD	Common Stock	Sale	-$2.46M	-16.9K	-55.79%	$145.31	13.4K	Oct 29, 2021	Direct	F2
transaction	CNMD	Common Stock	Sale	-$817K	-5.59K	-41.72%	$146.14	7.81K	Oct 29, 2021	Direct	F3
transaction	CNMD	Common Stock	Options Exercise	$2.6M	+50.7K	+649.42%	$51.30	58.5K	Oct 29, 2021	Direct
transaction	CNMD	Common Stock	Tax liability	-$4.86M	-33.3K	-56.84%	$146.28	25.3K	Oct 29, 2021	Direct

Showing 1 to 7 of 7 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNMD	Options To Purchase Common Stock	Options Exercise	$0	-55.3K	-100%	$0.00^*	0	Oct 29, 2021	Common Stock	55.3K	$39.87	Direct	F4
transaction	CNMD	Sars (Stock Appreciation Rights)	Options Exercise	$0	-50.7K	-100%	$0.00^*	0	Oct 29, 2021	Common Stock	50.7K	$51.30	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.90 to $144.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.92 to $145.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.93 to $146.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4	The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5	The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Plan and generally vest in equal amounts (20%) over a five year period.